nodes	percent_of_prediction	percent_of_DWPC	metapath
Itraconazole—CYP3A4—bone cancer	0.581	1	CbGaD
Itraconazole—CYP2B6—Cisplatin—bone cancer	0.0402	0.295	CbGbCtD
Itraconazole—CYP2B6—Doxorubicin—bone cancer	0.027	0.198	CbGbCtD
Itraconazole—ABCB1—Cisplatin—bone cancer	0.0206	0.151	CbGbCtD
Itraconazole—ABCB1—Doxorubicin—bone cancer	0.0138	0.101	CbGbCtD
Itraconazole—ABCB1—Methotrexate—bone cancer	0.0134	0.0982	CbGbCtD
Itraconazole—CYP2D6—Doxorubicin—bone cancer	0.013	0.0955	CbGbCtD
Itraconazole—CYP3A4—Doxorubicin—bone cancer	0.00828	0.0607	CbGbCtD
Itraconazole—CYP51A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00519	0.0672	CbGpPWpGaD
Itraconazole—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00513	0.0663	CbGpPWpGaD
Itraconazole—Posaconazole—CYP3A4—bone cancer	0.00359	0.761	CrCbGaD
Itraconazole—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00232	0.03	CbGpPWpGaD
Itraconazole—CYP51A1—Metapathway biotransformation—CYP4V2—bone cancer	0.00224	0.0289	CbGpPWpGaD
Itraconazole—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00172	0.0222	CbGpPWpGaD
Itraconazole—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00168	0.0218	CbGpPWpGaD
Itraconazole—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00168	0.0217	CbGpPWpGaD
Itraconazole—CYP1A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00159	0.0205	CbGpPWpGaD
Itraconazole—CYP1A1—Benzo(a)pyrene metabolism—CYP3A4—bone cancer	0.00145	0.0188	CbGpPWpGaD
Itraconazole—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.00144	0.0187	CbGpPWpGaD
Itraconazole—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00127	0.0165	CbGpPWpGaD
Itraconazole—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.0012	0.0155	CbGpPWpGaD
Itraconazole—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00119	0.0154	CbGpPWpGaD
Itraconazole—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00119	0.0154	CbGpPWpGaD
Itraconazole—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00119	0.0154	CbGpPWpGaD
Itraconazole—Ketoconazole—CYP3A4—bone cancer	0.00113	0.239	CrCbGaD
Itraconazole—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.00112	0.0145	CbGpPWpGaD
Itraconazole—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.00108	0.0139	CbGpPWpGaD
Itraconazole—CYP51A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00104	0.0135	CbGpPWpGaD
Itraconazole—CYP51A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00103	0.0133	CbGpPWpGaD
Itraconazole—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.001	0.0129	CbGpPWpGaD
Itraconazole—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000971	0.0126	CbGpPWpGaD
Itraconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000929	0.012	CbGpPWpGaD
Itraconazole—CYP1A1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000916	0.0118	CbGpPWpGaD
Itraconazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00091	0.0118	CbGpPWpGaD
Itraconazole—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000845	0.0109	CbGpPWpGaD
Itraconazole—CYP51A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000844	0.0109	CbGpPWpGaD
Itraconazole—CYP1A1—Estrogen metabolism—CYP3A4—bone cancer	0.000833	0.0108	CbGpPWpGaD
Itraconazole—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000829	0.0107	CbGpPWpGaD
Itraconazole—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.000812	0.0105	CbGpPWpGaD
Itraconazole—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000811	0.0105	CbGpPWpGaD
Itraconazole—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000781	0.0101	CbGpPWpGaD
Itraconazole—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000781	0.0101	CbGpPWpGaD
Itraconazole—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.00078	0.0101	CbGpPWpGaD
Itraconazole—CYP1A1—Xenobiotics—CYP3A4—bone cancer	0.000766	0.0099	CbGpPWpGaD
Itraconazole—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.00074	0.00956	CbGpPWpGaD
Itraconazole—CYP1A1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000737	0.00952	CbGpPWpGaD
Itraconazole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000735	0.0095	CbGpPWpGaD
Itraconazole—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000724	0.00937	CbGpPWpGaD
Itraconazole—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000723	0.00935	CbGpPWpGaD
Itraconazole—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000697	0.00901	CbGpPWpGaD
Itraconazole—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000689	0.00891	CbGpPWpGaD
Itraconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000685	0.00885	CbGpPWpGaD
Itraconazole—CYP1A1—Metapathway biotransformation—CYP4V2—bone cancer	0.000683	0.00883	CbGpPWpGaD
Itraconazole—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000576	0.00745	CbGpPWpGaD
Itraconazole—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000569	0.00736	CbGpPWpGaD
Itraconazole—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000557	0.0072	CbGpPWpGaD
Itraconazole—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000554	0.00717	CbGpPWpGaD
Itraconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000543	0.00701	CbGpPWpGaD
Itraconazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000531	0.00687	CbGpPWpGaD
Itraconazole—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000514	0.00665	CbGpPWpGaD
Itraconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000466	0.00602	CbGpPWpGaD
Itraconazole—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00046	0.00594	CbGpPWpGaD
Itraconazole—CYP51A1—Biological oxidations—CYP3A4—bone cancer	0.000448	0.0058	CbGpPWpGaD
Itraconazole—CYP51A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000442	0.00572	CbGpPWpGaD
Itraconazole—CYP1A1—Estrogen Receptor Pathway—JUN—bone cancer	0.000432	0.00558	CbGpPWpGaD
Itraconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000422	0.00546	CbGpPWpGaD
Itraconazole—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00042	0.00543	CbGpPWpGaD
Itraconazole—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000417	0.00539	CbGpPWpGaD
Itraconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.0004	0.00517	CbGpPWpGaD
Itraconazole—CYP1A1—Tryptophan metabolism—CYP3A4—bone cancer	0.000393	0.00509	CbGpPWpGaD
Itraconazole—CYP51A1—Biological oxidations—GSTP1—bone cancer	0.000383	0.00496	CbGpPWpGaD
Itraconazole—CYP51A1—Metapathway biotransformation—GSTP1—bone cancer	0.000378	0.00489	CbGpPWpGaD
Itraconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000378	0.00488	CbGpPWpGaD
Itraconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000344	0.00445	CbGpPWpGaD
Itraconazole—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00034	0.00439	CbGpPWpGaD
Itraconazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000337	0.00436	CbGpPWpGaD
Itraconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000337	0.00435	CbGpPWpGaD
Itraconazole—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000336	0.00435	CbGpPWpGaD
Itraconazole—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000333	0.0043	CbGpPWpGaD
Itraconazole—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000332	0.00429	CbGpPWpGaD
Itraconazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000318	0.00411	CbGpPWpGaD
Itraconazole—CYP1A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000314	0.00406	CbGpPWpGaD
Itraconazole—Neuropathy peripheral—Epirubicin—bone cancer	0.000283	0.00141	CcSEcCtD
Itraconazole—Jaundice—Epirubicin—bone cancer	0.000282	0.00141	CcSEcCtD
Itraconazole—Urinary tract infection—Epirubicin—bone cancer	0.000281	0.0014	CcSEcCtD
Itraconazole—Neutropenia—Doxorubicin—bone cancer	0.00028	0.0014	CcSEcCtD
Itraconazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000279	0.00361	CbGpPWpGaD
Itraconazole—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000279	0.00139	CcSEcCtD
Itraconazole—Hepatitis—Methotrexate—bone cancer	0.000277	0.00138	CcSEcCtD
Itraconazole—Pollakiuria—Doxorubicin—bone cancer	0.000277	0.00138	CcSEcCtD
Itraconazole—Haematuria—Epirubicin—bone cancer	0.000275	0.00138	CcSEcCtD
Itraconazole—Pharyngitis—Methotrexate—bone cancer	0.000275	0.00137	CcSEcCtD
Itraconazole—Urinary tract disorder—Methotrexate—bone cancer	0.000274	0.00137	CcSEcCtD
Itraconazole—Photosensitivity reaction—Doxorubicin—bone cancer	0.000274	0.00137	CcSEcCtD
Itraconazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000273	0.00354	CbGpPWpGaD
Itraconazole—Hepatobiliary disease—Epirubicin—bone cancer	0.000273	0.00136	CcSEcCtD
Itraconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000273	0.00353	CbGpPWpGaD
Itraconazole—Urethral disorder—Methotrexate—bone cancer	0.000272	0.00136	CcSEcCtD
Itraconazole—Weight decreased—Doxorubicin—bone cancer	0.000271	0.00136	CcSEcCtD
Itraconazole—Sinusitis—Epirubicin—bone cancer	0.000271	0.00135	CcSEcCtD
Itraconazole—Hyperglycaemia—Doxorubicin—bone cancer	0.00027	0.00135	CcSEcCtD
Itraconazole—Agranulocytosis—Epirubicin—bone cancer	0.00027	0.00135	CcSEcCtD
Itraconazole—Pneumonia—Doxorubicin—bone cancer	0.000269	0.00134	CcSEcCtD
Itraconazole—CYP51A1—Metabolism—NDUFA12—bone cancer	0.000269	0.00347	CbGpPWpGaD
Itraconazole—Infestation—Doxorubicin—bone cancer	0.000267	0.00134	CcSEcCtD
Itraconazole—Infestation NOS—Doxorubicin—bone cancer	0.000267	0.00134	CcSEcCtD
Itraconazole—Drowsiness—Doxorubicin—bone cancer	0.000267	0.00134	CcSEcCtD
Itraconazole—Visual impairment—Methotrexate—bone cancer	0.000267	0.00133	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000265	0.00132	CcSEcCtD
Itraconazole—Hypersensitivity—Cisplatin—bone cancer	0.000264	0.00132	CcSEcCtD
Itraconazole—Renal failure—Doxorubicin—bone cancer	0.000263	0.00131	CcSEcCtD
Itraconazole—Erythema multiforme—Methotrexate—bone cancer	0.000262	0.00131	CcSEcCtD
Itraconazole—Neuropathy peripheral—Doxorubicin—bone cancer	0.000262	0.00131	CcSEcCtD
Itraconazole—Jaundice—Doxorubicin—bone cancer	0.00026	0.0013	CcSEcCtD
Itraconazole—Rhinitis—Epirubicin—bone cancer	0.00026	0.0013	CcSEcCtD
Itraconazole—Urinary tract infection—Doxorubicin—bone cancer	0.00026	0.0013	CcSEcCtD
Itraconazole—Hepatitis—Epirubicin—bone cancer	0.000259	0.0013	CcSEcCtD
Itraconazole—Eye disorder—Methotrexate—bone cancer	0.000259	0.00129	CcSEcCtD
Itraconazole—Tinnitus—Methotrexate—bone cancer	0.000258	0.00129	CcSEcCtD
Itraconazole—Hypoaesthesia—Epirubicin—bone cancer	0.000258	0.00129	CcSEcCtD
Itraconazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000258	0.00333	CbGpPWpGaD
Itraconazole—Asthenia—Cisplatin—bone cancer	0.000257	0.00129	CcSEcCtD
Itraconazole—Pharyngitis—Epirubicin—bone cancer	0.000257	0.00129	CcSEcCtD
Itraconazole—Cardiac disorder—Methotrexate—bone cancer	0.000257	0.00128	CcSEcCtD
Itraconazole—Urinary tract disorder—Epirubicin—bone cancer	0.000256	0.00128	CcSEcCtD
Itraconazole—Oedema peripheral—Epirubicin—bone cancer	0.000255	0.00128	CcSEcCtD
Itraconazole—Haematuria—Doxorubicin—bone cancer	0.000255	0.00127	CcSEcCtD
Itraconazole—Connective tissue disorder—Epirubicin—bone cancer	0.000255	0.00127	CcSEcCtD
Itraconazole—Urethral disorder—Epirubicin—bone cancer	0.000254	0.00127	CcSEcCtD
Itraconazole—Hepatobiliary disease—Doxorubicin—bone cancer	0.000253	0.00126	CcSEcCtD
Itraconazole—Angiopathy—Methotrexate—bone cancer	0.000251	0.00126	CcSEcCtD
Itraconazole—Sinusitis—Doxorubicin—bone cancer	0.000251	0.00125	CcSEcCtD
Itraconazole—Immune system disorder—Methotrexate—bone cancer	0.00025	0.00125	CcSEcCtD
Itraconazole—Visual impairment—Epirubicin—bone cancer	0.00025	0.00125	CcSEcCtD
Itraconazole—Mediastinal disorder—Methotrexate—bone cancer	0.00025	0.00125	CcSEcCtD
Itraconazole—Agranulocytosis—Doxorubicin—bone cancer	0.000249	0.00125	CcSEcCtD
Itraconazole—Chills—Methotrexate—bone cancer	0.000249	0.00124	CcSEcCtD
Itraconazole—Diarrhoea—Cisplatin—bone cancer	0.000245	0.00123	CcSEcCtD
Itraconazole—Erythema multiforme—Epirubicin—bone cancer	0.000245	0.00123	CcSEcCtD
Itraconazole—Alopecia—Methotrexate—bone cancer	0.000245	0.00122	CcSEcCtD
Itraconazole—Mental disorder—Methotrexate—bone cancer	0.000243	0.00121	CcSEcCtD
Itraconazole—Eye disorder—Epirubicin—bone cancer	0.000242	0.00121	CcSEcCtD
Itraconazole—Tinnitus—Epirubicin—bone cancer	0.000242	0.00121	CcSEcCtD
Itraconazole—Malnutrition—Methotrexate—bone cancer	0.000241	0.00121	CcSEcCtD
Itraconazole—Cardiac disorder—Epirubicin—bone cancer	0.000241	0.0012	CcSEcCtD
Itraconazole—Rhinitis—Doxorubicin—bone cancer	0.00024	0.0012	CcSEcCtD
Itraconazole—Hepatitis—Doxorubicin—bone cancer	0.00024	0.0012	CcSEcCtD
Itraconazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000239	0.00309	CbGpPWpGaD
Itraconazole—Hypoaesthesia—Doxorubicin—bone cancer	0.000239	0.00119	CcSEcCtD
Itraconazole—Pharyngitis—Doxorubicin—bone cancer	0.000238	0.00119	CcSEcCtD
Itraconazole—Urinary tract disorder—Doxorubicin—bone cancer	0.000237	0.00118	CcSEcCtD
Itraconazole—Oedema peripheral—Doxorubicin—bone cancer	0.000236	0.00118	CcSEcCtD
Itraconazole—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000236	0.00305	CbGpPWpGaD
Itraconazole—Dysgeusia—Methotrexate—bone cancer	0.000236	0.00118	CcSEcCtD
Itraconazole—Connective tissue disorder—Doxorubicin—bone cancer	0.000236	0.00118	CcSEcCtD
Itraconazole—Angiopathy—Epirubicin—bone cancer	0.000235	0.00118	CcSEcCtD
Itraconazole—Urethral disorder—Doxorubicin—bone cancer	0.000235	0.00118	CcSEcCtD
Itraconazole—Immune system disorder—Epirubicin—bone cancer	0.000234	0.00117	CcSEcCtD
Itraconazole—Mediastinal disorder—Epirubicin—bone cancer	0.000234	0.00117	CcSEcCtD
Itraconazole—Back pain—Methotrexate—bone cancer	0.000233	0.00117	CcSEcCtD
Itraconazole—Chills—Epirubicin—bone cancer	0.000233	0.00116	CcSEcCtD
Itraconazole—Arrhythmia—Epirubicin—bone cancer	0.000232	0.00116	CcSEcCtD
Itraconazole—Visual impairment—Doxorubicin—bone cancer	0.000231	0.00116	CcSEcCtD
Itraconazole—Alopecia—Epirubicin—bone cancer	0.000229	0.00114	CcSEcCtD
Itraconazole—Vomiting—Cisplatin—bone cancer	0.000228	0.00114	CcSEcCtD
Itraconazole—Vision blurred—Methotrexate—bone cancer	0.000227	0.00114	CcSEcCtD
Itraconazole—Mental disorder—Epirubicin—bone cancer	0.000227	0.00114	CcSEcCtD
Itraconazole—Erythema multiforme—Doxorubicin—bone cancer	0.000227	0.00113	CcSEcCtD
Itraconazole—Rash—Cisplatin—bone cancer	0.000226	0.00113	CcSEcCtD
Itraconazole—Dermatitis—Cisplatin—bone cancer	0.000226	0.00113	CcSEcCtD
Itraconazole—Malnutrition—Epirubicin—bone cancer	0.000226	0.00113	CcSEcCtD
Itraconazole—Eye disorder—Doxorubicin—bone cancer	0.000224	0.00112	CcSEcCtD
Itraconazole—Ill-defined disorder—Methotrexate—bone cancer	0.000224	0.00112	CcSEcCtD
Itraconazole—Tinnitus—Doxorubicin—bone cancer	0.000224	0.00112	CcSEcCtD
Itraconazole—CYP51A1—Metabolism—NT5C3A—bone cancer	0.000223	0.00288	CbGpPWpGaD
Itraconazole—Cardiac disorder—Doxorubicin—bone cancer	0.000223	0.00111	CcSEcCtD
Itraconazole—Flatulence—Epirubicin—bone cancer	0.000222	0.00111	CcSEcCtD
Itraconazole—Dysgeusia—Epirubicin—bone cancer	0.000221	0.0011	CcSEcCtD
Itraconazole—Back pain—Epirubicin—bone cancer	0.000218	0.00109	CcSEcCtD
Itraconazole—Angiopathy—Doxorubicin—bone cancer	0.000218	0.00109	CcSEcCtD
Itraconazole—Malaise—Methotrexate—bone cancer	0.000217	0.00109	CcSEcCtD
Itraconazole—Immune system disorder—Doxorubicin—bone cancer	0.000217	0.00108	CcSEcCtD
Itraconazole—Vertigo—Methotrexate—bone cancer	0.000217	0.00108	CcSEcCtD
Itraconazole—Mediastinal disorder—Doxorubicin—bone cancer	0.000216	0.00108	CcSEcCtD
Itraconazole—Leukopenia—Methotrexate—bone cancer	0.000216	0.00108	CcSEcCtD
Itraconazole—Chills—Doxorubicin—bone cancer	0.000215	0.00108	CcSEcCtD
Itraconazole—Arrhythmia—Doxorubicin—bone cancer	0.000214	0.00107	CcSEcCtD
Itraconazole—Nausea—Cisplatin—bone cancer	0.000213	0.00106	CcSEcCtD
Itraconazole—Vision blurred—Epirubicin—bone cancer	0.000213	0.00106	CcSEcCtD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000212	0.00274	CbGpPWpGaD
Itraconazole—Alopecia—Doxorubicin—bone cancer	0.000212	0.00106	CcSEcCtD
Itraconazole—Cough—Methotrexate—bone cancer	0.00021	0.00105	CcSEcCtD
Itraconazole—Mental disorder—Doxorubicin—bone cancer	0.00021	0.00105	CcSEcCtD
Itraconazole—Ill-defined disorder—Epirubicin—bone cancer	0.000209	0.00105	CcSEcCtD
Itraconazole—Malnutrition—Doxorubicin—bone cancer	0.000209	0.00104	CcSEcCtD
Itraconazole—Flatulence—Doxorubicin—bone cancer	0.000206	0.00103	CcSEcCtD
Itraconazole—Arthralgia—Methotrexate—bone cancer	0.000205	0.00103	CcSEcCtD
Itraconazole—Chest pain—Methotrexate—bone cancer	0.000205	0.00103	CcSEcCtD
Itraconazole—Myalgia—Methotrexate—bone cancer	0.000205	0.00103	CcSEcCtD
Itraconazole—Dysgeusia—Doxorubicin—bone cancer	0.000204	0.00102	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000204	0.00102	CcSEcCtD
Itraconazole—Malaise—Epirubicin—bone cancer	0.000204	0.00102	CcSEcCtD
Itraconazole—Discomfort—Methotrexate—bone cancer	0.000203	0.00101	CcSEcCtD
Itraconazole—Vertigo—Epirubicin—bone cancer	0.000203	0.00101	CcSEcCtD
Itraconazole—Syncope—Epirubicin—bone cancer	0.000202	0.00101	CcSEcCtD
Itraconazole—Leukopenia—Epirubicin—bone cancer	0.000202	0.00101	CcSEcCtD
Itraconazole—Back pain—Doxorubicin—bone cancer	0.000202	0.00101	CcSEcCtD
Itraconazole—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000201	0.00259	CbGpPWpGaD
Itraconazole—Confusional state—Methotrexate—bone cancer	0.000198	0.000992	CcSEcCtD
Itraconazole—Loss of consciousness—Epirubicin—bone cancer	0.000198	0.000991	CcSEcCtD
Itraconazole—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000198	0.00256	CbGpPWpGaD
Itraconazole—Cough—Epirubicin—bone cancer	0.000197	0.000984	CcSEcCtD
Itraconazole—Anaphylactic shock—Methotrexate—bone cancer	0.000197	0.000984	CcSEcCtD
Itraconazole—Vision blurred—Doxorubicin—bone cancer	0.000197	0.000984	CcSEcCtD
Itraconazole—Infection—Methotrexate—bone cancer	0.000196	0.000977	CcSEcCtD
Itraconazole—Hypertension—Epirubicin—bone cancer	0.000195	0.000974	CcSEcCtD
Itraconazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000194	0.00251	CbGpPWpGaD
Itraconazole—Ill-defined disorder—Doxorubicin—bone cancer	0.000194	0.000968	CcSEcCtD
Itraconazole—Nervous system disorder—Methotrexate—bone cancer	0.000193	0.000965	CcSEcCtD
Itraconazole—Thrombocytopenia—Methotrexate—bone cancer	0.000193	0.000963	CcSEcCtD
Itraconazole—Arthralgia—Epirubicin—bone cancer	0.000192	0.00096	CcSEcCtD
Itraconazole—Chest pain—Epirubicin—bone cancer	0.000192	0.00096	CcSEcCtD
Itraconazole—Myalgia—Epirubicin—bone cancer	0.000192	0.00096	CcSEcCtD
Itraconazole—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000192	0.00248	CbGpPWpGaD
Itraconazole—Anxiety—Epirubicin—bone cancer	0.000191	0.000957	CcSEcCtD
Itraconazole—Skin disorder—Methotrexate—bone cancer	0.000191	0.000955	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000191	0.000954	CcSEcCtD
Itraconazole—Hyperhidrosis—Methotrexate—bone cancer	0.00019	0.000951	CcSEcCtD
Itraconazole—Discomfort—Epirubicin—bone cancer	0.00019	0.000949	CcSEcCtD
Itraconazole—Malaise—Doxorubicin—bone cancer	0.000188	0.000941	CcSEcCtD
Itraconazole—Vertigo—Doxorubicin—bone cancer	0.000188	0.000938	CcSEcCtD
Itraconazole—Anorexia—Methotrexate—bone cancer	0.000188	0.000938	CcSEcCtD
Itraconazole—Syncope—Doxorubicin—bone cancer	0.000187	0.000936	CcSEcCtD
Itraconazole—Leukopenia—Doxorubicin—bone cancer	0.000187	0.000934	CcSEcCtD
Itraconazole—Confusional state—Epirubicin—bone cancer	0.000186	0.000928	CcSEcCtD
Itraconazole—Oedema—Epirubicin—bone cancer	0.000184	0.00092	CcSEcCtD
Itraconazole—Anaphylactic shock—Epirubicin—bone cancer	0.000184	0.00092	CcSEcCtD
Itraconazole—Hypotension—Methotrexate—bone cancer	0.000184	0.000919	CcSEcCtD
Itraconazole—Loss of consciousness—Doxorubicin—bone cancer	0.000184	0.000917	CcSEcCtD
Itraconazole—Infection—Epirubicin—bone cancer	0.000183	0.000914	CcSEcCtD
Itraconazole—Cough—Doxorubicin—bone cancer	0.000182	0.000911	CcSEcCtD
Itraconazole—Shock—Epirubicin—bone cancer	0.000181	0.000906	CcSEcCtD
Itraconazole—CYP1A1—Tryptophan metabolism—MDM2—bone cancer	0.000181	0.00234	CbGpPWpGaD
Itraconazole—Nervous system disorder—Epirubicin—bone cancer	0.000181	0.000903	CcSEcCtD
Itraconazole—Thrombocytopenia—Epirubicin—bone cancer	0.00018	0.000901	CcSEcCtD
Itraconazole—Hypertension—Doxorubicin—bone cancer	0.00018	0.000901	CcSEcCtD
Itraconazole—Tachycardia—Epirubicin—bone cancer	0.00018	0.000898	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000179	0.000896	CcSEcCtD
Itraconazole—Skin disorder—Epirubicin—bone cancer	0.000179	0.000894	CcSEcCtD
Itraconazole—Hyperhidrosis—Epirubicin—bone cancer	0.000178	0.00089	CcSEcCtD
Itraconazole—Insomnia—Methotrexate—bone cancer	0.000178	0.00089	CcSEcCtD
Itraconazole—Chest pain—Doxorubicin—bone cancer	0.000178	0.000888	CcSEcCtD
Itraconazole—Myalgia—Doxorubicin—bone cancer	0.000178	0.000888	CcSEcCtD
Itraconazole—Arthralgia—Doxorubicin—bone cancer	0.000178	0.000888	CcSEcCtD
Itraconazole—Anxiety—Doxorubicin—bone cancer	0.000177	0.000885	CcSEcCtD
Itraconazole—Paraesthesia—Methotrexate—bone cancer	0.000177	0.000883	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000177	0.000882	CcSEcCtD
Itraconazole—Discomfort—Doxorubicin—bone cancer	0.000176	0.000878	CcSEcCtD
Itraconazole—Anorexia—Epirubicin—bone cancer	0.000176	0.000877	CcSEcCtD
Itraconazole—Dyspnoea—Methotrexate—bone cancer	0.000175	0.000877	CcSEcCtD
Itraconazole—Somnolence—Methotrexate—bone cancer	0.000175	0.000874	CcSEcCtD
Itraconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000174	0.00225	CbGpPWpGaD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000174	0.00225	CbGpPWpGaD
Itraconazole—Dyspepsia—Methotrexate—bone cancer	0.000173	0.000866	CcSEcCtD
Itraconazole—Hypotension—Epirubicin—bone cancer	0.000172	0.00086	CcSEcCtD
Itraconazole—Confusional state—Doxorubicin—bone cancer	0.000172	0.000859	CcSEcCtD
Itraconazole—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000172	0.00222	CbGpPWpGaD
Itraconazole—Decreased appetite—Methotrexate—bone cancer	0.000171	0.000855	CcSEcCtD
Itraconazole—Anaphylactic shock—Doxorubicin—bone cancer	0.00017	0.000852	CcSEcCtD
Itraconazole—Oedema—Doxorubicin—bone cancer	0.00017	0.000852	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Methotrexate—bone cancer	0.00017	0.000849	CcSEcCtD
Itraconazole—Fatigue—Methotrexate—bone cancer	0.00017	0.000848	CcSEcCtD
Itraconazole—Infection—Doxorubicin—bone cancer	0.000169	0.000846	CcSEcCtD
Itraconazole—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000169	0.00219	CbGpPWpGaD
Itraconazole—Pain—Methotrexate—bone cancer	0.000168	0.000841	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000168	0.000839	CcSEcCtD
Itraconazole—Shock—Doxorubicin—bone cancer	0.000168	0.000838	CcSEcCtD
Itraconazole—Nervous system disorder—Doxorubicin—bone cancer	0.000167	0.000835	CcSEcCtD
Itraconazole—Thrombocytopenia—Doxorubicin—bone cancer	0.000167	0.000834	CcSEcCtD
Itraconazole—Insomnia—Epirubicin—bone cancer	0.000167	0.000833	CcSEcCtD
Itraconazole—Tachycardia—Doxorubicin—bone cancer	0.000166	0.000831	CcSEcCtD
Itraconazole—Skin disorder—Doxorubicin—bone cancer	0.000166	0.000827	CcSEcCtD
Itraconazole—Paraesthesia—Epirubicin—bone cancer	0.000165	0.000827	CcSEcCtD
Itraconazole—Hyperhidrosis—Doxorubicin—bone cancer	0.000165	0.000823	CcSEcCtD
Itraconazole—Dyspnoea—Epirubicin—bone cancer	0.000164	0.000821	CcSEcCtD
Itraconazole—Somnolence—Epirubicin—bone cancer	0.000164	0.000818	CcSEcCtD
Itraconazole—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000163	0.00211	CbGpPWpGaD
Itraconazole—Anorexia—Doxorubicin—bone cancer	0.000162	0.000812	CcSEcCtD
Itraconazole—Feeling abnormal—Methotrexate—bone cancer	0.000162	0.000811	CcSEcCtD
Itraconazole—Dyspepsia—Epirubicin—bone cancer	0.000162	0.00081	CcSEcCtD
Itraconazole—Gastrointestinal pain—Methotrexate—bone cancer	0.000161	0.000804	CcSEcCtD
Itraconazole—Decreased appetite—Epirubicin—bone cancer	0.00016	0.0008	CcSEcCtD
Itraconazole—Hypotension—Doxorubicin—bone cancer	0.000159	0.000796	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Epirubicin—bone cancer	0.000159	0.000795	CcSEcCtD
Itraconazole—Fatigue—Epirubicin—bone cancer	0.000159	0.000794	CcSEcCtD
Itraconazole—Constipation—Epirubicin—bone cancer	0.000158	0.000787	CcSEcCtD
Itraconazole—Pain—Epirubicin—bone cancer	0.000158	0.000787	CcSEcCtD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000157	0.00203	CbGpPWpGaD
Itraconazole—Urticaria—Methotrexate—bone cancer	0.000156	0.000781	CcSEcCtD
Itraconazole—Abdominal pain—Methotrexate—bone cancer	0.000156	0.000778	CcSEcCtD
Itraconazole—Body temperature increased—Methotrexate—bone cancer	0.000156	0.000778	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000155	0.000776	CcSEcCtD
Itraconazole—Insomnia—Doxorubicin—bone cancer	0.000154	0.00077	CcSEcCtD
Itraconazole—Paraesthesia—Doxorubicin—bone cancer	0.000153	0.000765	CcSEcCtD
Itraconazole—Dyspnoea—Doxorubicin—bone cancer	0.000152	0.000759	CcSEcCtD
Itraconazole—Feeling abnormal—Epirubicin—bone cancer	0.000152	0.000759	CcSEcCtD
Itraconazole—Somnolence—Doxorubicin—bone cancer	0.000152	0.000757	CcSEcCtD
Itraconazole—Gastrointestinal pain—Epirubicin—bone cancer	0.000151	0.000753	CcSEcCtD
Itraconazole—Dyspepsia—Doxorubicin—bone cancer	0.00015	0.00075	CcSEcCtD
Itraconazole—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000148	0.00192	CbGpPWpGaD
Itraconazole—Decreased appetite—Doxorubicin—bone cancer	0.000148	0.00074	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000147	0.000735	CcSEcCtD
Itraconazole—Fatigue—Doxorubicin—bone cancer	0.000147	0.000734	CcSEcCtD
Itraconazole—Urticaria—Epirubicin—bone cancer	0.000146	0.000731	CcSEcCtD
Itraconazole—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000146	0.00189	CbGpPWpGaD
Itraconazole—Constipation—Doxorubicin—bone cancer	0.000146	0.000728	CcSEcCtD
Itraconazole—Pain—Doxorubicin—bone cancer	0.000146	0.000728	CcSEcCtD
Itraconazole—Body temperature increased—Epirubicin—bone cancer	0.000146	0.000728	CcSEcCtD
Itraconazole—Abdominal pain—Epirubicin—bone cancer	0.000146	0.000728	CcSEcCtD
Itraconazole—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000145	0.00188	CbGpPWpGaD
Itraconazole—Hypersensitivity—Methotrexate—bone cancer	0.000145	0.000725	CcSEcCtD
Itraconazole—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000145	0.00187	CbGpPWpGaD
Itraconazole—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000143	0.00185	CbGpPWpGaD
Itraconazole—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000143	0.00185	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000143	0.00184	CbGpPWpGaD
Itraconazole—Asthenia—Methotrexate—bone cancer	0.000141	0.000706	CcSEcCtD
Itraconazole—Feeling abnormal—Doxorubicin—bone cancer	0.00014	0.000702	CcSEcCtD
Itraconazole—Gastrointestinal pain—Doxorubicin—bone cancer	0.000139	0.000696	CcSEcCtD
Itraconazole—Pruritus—Methotrexate—bone cancer	0.000139	0.000696	CcSEcCtD
Itraconazole—CYP1A1—Biological oxidations—CYP3A4—bone cancer	0.000137	0.00177	CbGpPWpGaD
Itraconazole—Hypersensitivity—Epirubicin—bone cancer	0.000136	0.000678	CcSEcCtD
Itraconazole—Urticaria—Doxorubicin—bone cancer	0.000135	0.000677	CcSEcCtD
Itraconazole—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000135	0.00175	CbGpPWpGaD
Itraconazole—Body temperature increased—Doxorubicin—bone cancer	0.000135	0.000673	CcSEcCtD
Itraconazole—Abdominal pain—Doxorubicin—bone cancer	0.000135	0.000673	CcSEcCtD
Itraconazole—Diarrhoea—Methotrexate—bone cancer	0.000135	0.000673	CcSEcCtD
Itraconazole—Asthenia—Epirubicin—bone cancer	0.000132	0.00066	CcSEcCtD
Itraconazole—Pruritus—Epirubicin—bone cancer	0.00013	0.000651	CcSEcCtD
Itraconazole—Dizziness—Methotrexate—bone cancer	0.00013	0.00065	CcSEcCtD
Itraconazole—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000127	0.00164	CbGpPWpGaD
Itraconazole—Diarrhoea—Epirubicin—bone cancer	0.000126	0.00063	CcSEcCtD
Itraconazole—Hypersensitivity—Doxorubicin—bone cancer	0.000126	0.000628	CcSEcCtD
Itraconazole—Vomiting—Methotrexate—bone cancer	0.000125	0.000625	CcSEcCtD
Itraconazole—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000125	0.00162	CbGpPWpGaD
Itraconazole—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000124	0.00161	CbGpPWpGaD
Itraconazole—Rash—Methotrexate—bone cancer	0.000124	0.00062	CcSEcCtD
Itraconazole—Dermatitis—Methotrexate—bone cancer	0.000124	0.00062	CcSEcCtD
Itraconazole—CYP3A5—Biological oxidations—GSTP1—bone cancer	0.000124	0.0016	CbGpPWpGaD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000124	0.0016	CbGpPWpGaD
Itraconazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000124	0.0016	CbGpPWpGaD
Itraconazole—Headache—Methotrexate—bone cancer	0.000123	0.000616	CcSEcCtD
Itraconazole—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000123	0.00158	CbGpPWpGaD
Itraconazole—Asthenia—Doxorubicin—bone cancer	0.000122	0.000611	CcSEcCtD
Itraconazole—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	0.000122	0.00158	CbGpPWpGaD
Itraconazole—Dizziness—Epirubicin—bone cancer	0.000122	0.000609	CcSEcCtD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000121	0.00157	CbGpPWpGaD
Itraconazole—Pruritus—Doxorubicin—bone cancer	0.000121	0.000603	CcSEcCtD
Itraconazole—CYP3A7—Metabolism—NDUFA12—bone cancer	0.00012	0.00155	CbGpPWpGaD
Itraconazole—CYP1A1—Biological oxidations—GSTP1—bone cancer	0.000117	0.00151	CbGpPWpGaD
Itraconazole—Vomiting—Epirubicin—bone cancer	0.000117	0.000585	CcSEcCtD
Itraconazole—Nausea—Methotrexate—bone cancer	0.000117	0.000584	CcSEcCtD
Itraconazole—Diarrhoea—Doxorubicin—bone cancer	0.000117	0.000583	CcSEcCtD
Itraconazole—Rash—Epirubicin—bone cancer	0.000116	0.00058	CcSEcCtD
Itraconazole—Dermatitis—Epirubicin—bone cancer	0.000116	0.00058	CcSEcCtD
Itraconazole—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	0.000116	0.00149	CbGpPWpGaD
Itraconazole—Headache—Epirubicin—bone cancer	0.000115	0.000577	CcSEcCtD
Itraconazole—Dizziness—Doxorubicin—bone cancer	0.000113	0.000563	CcSEcCtD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00011	0.00143	CbGpPWpGaD
Itraconazole—Nausea—Epirubicin—bone cancer	0.000109	0.000547	CcSEcCtD
Itraconazole—Vomiting—Doxorubicin—bone cancer	0.000108	0.000542	CcSEcCtD
Itraconazole—Rash—Doxorubicin—bone cancer	0.000107	0.000537	CcSEcCtD
Itraconazole—Dermatitis—Doxorubicin—bone cancer	0.000107	0.000537	CcSEcCtD
Itraconazole—Headache—Doxorubicin—bone cancer	0.000107	0.000534	CcSEcCtD
Itraconazole—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.000103	0.00133	CbGpPWpGaD
Itraconazole—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000102	0.00131	CbGpPWpGaD
Itraconazole—Nausea—Doxorubicin—bone cancer	0.000101	0.000506	CcSEcCtD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000101	0.0013	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—NT5C3A—bone cancer	9.96e-05	0.00129	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.92e-05	0.00128	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—ENO2—bone cancer	9.75e-05	0.00126	CbGpPWpGaD
Itraconazole—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	9.4e-05	0.00122	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—DHFR—bone cancer	9.05e-05	0.00117	CbGpPWpGaD
Itraconazole—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.9e-05	0.00115	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—NDUFA12—bone cancer	8.89e-05	0.00115	CbGpPWpGaD
Itraconazole—CYP2D6—Biological oxidations—GSTP1—bone cancer	8.82e-05	0.00114	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—NDUFA12—bone cancer	8.71e-05	0.00113	CbGpPWpGaD
Itraconazole—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	8.69e-05	0.00112	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—NDUFA12—bone cancer	8.69e-05	0.00112	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—GNA11—bone cancer	8.46e-05	0.00109	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.41e-05	0.00109	CbGpPWpGaD
Itraconazole—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.39e-05	0.00108	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—NDUFA12—bone cancer	8.21e-05	0.00106	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—CYP3A4—bone cancer	7.67e-05	0.000991	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.63e-05	0.000986	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—NT5C3A—bone cancer	7.37e-05	0.000952	CbGpPWpGaD
Itraconazole—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.24e-05	0.000936	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—NT5C3A—bone cancer	7.21e-05	0.000933	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—NT5C3A—bone cancer	7.2e-05	0.000931	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—NT5C3A—bone cancer	6.8e-05	0.000879	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—NDUFA12—bone cancer	6.56e-05	0.000848	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—GSTP1—bone cancer	6.56e-05	0.000848	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.24e-05	0.000806	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—NDUFA12—bone cancer	6.18e-05	0.000799	CbGpPWpGaD
Itraconazole—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.76e-05	0.000745	CbGpPWpGaD
Itraconazole—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.68e-05	0.000735	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—NT5C3A—bone cancer	5.43e-05	0.000702	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—NT5C3A—bone cancer	5.12e-05	0.000662	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.62e-05	0.000598	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.46e-05	0.000576	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—ENO2—bone cancer	4.36e-05	0.000564	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—DHFR—bone cancer	4.05e-05	0.000523	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—NDUFA12—bone cancer	4.04e-05	0.000522	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.02e-05	0.00052	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—GNA11—bone cancer	3.78e-05	0.000489	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—CYP3A4—bone cancer	3.43e-05	0.000443	CbGpPWpGaD
Itraconazole—CYP51A1—Metabolism—PTGS2—bone cancer	3.4e-05	0.000439	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—NT5C3A—bone cancer	3.35e-05	0.000433	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—ENO2—bone cancer	3.23e-05	0.000417	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—ENO2—bone cancer	3.16e-05	0.000409	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.16e-05	0.000408	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—ENO2—bone cancer	3.15e-05	0.000408	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—DHFR—bone cancer	2.99e-05	0.000387	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—ENO2—bone cancer	2.98e-05	0.000385	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—GSTP1—bone cancer	2.93e-05	0.000379	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—DHFR—bone cancer	2.93e-05	0.000379	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—DHFR—bone cancer	2.93e-05	0.000378	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—GNA11—bone cancer	2.8e-05	0.000362	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—DHFR—bone cancer	2.76e-05	0.000357	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—GNA11—bone cancer	2.74e-05	0.000354	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—GNA11—bone cancer	2.73e-05	0.000354	CbGpPWpGaD
Itraconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.65e-05	0.000343	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—GNA11—bone cancer	2.58e-05	0.000334	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—CYP3A4—bone cancer	2.54e-05	0.000328	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—CYP3A4—bone cancer	2.48e-05	0.000321	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—CYP3A4—bone cancer	2.48e-05	0.000321	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—ENO2—bone cancer	2.38e-05	0.000308	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—CYP3A4—bone cancer	2.34e-05	0.000303	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.33e-05	0.000301	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—ENO2—bone cancer	2.24e-05	0.00029	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—DHFR—bone cancer	2.21e-05	0.000285	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—GSTP1—bone cancer	2.17e-05	0.00028	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—GSTP1—bone cancer	2.12e-05	0.000275	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—GSTP1—bone cancer	2.12e-05	0.000274	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—DHFR—bone cancer	2.08e-05	0.000269	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—GNA11—bone cancer	2.06e-05	0.000267	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—GSTP1—bone cancer	2e-05	0.000259	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—GNA11—bone cancer	1.94e-05	0.000251	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—CYP3A4—bone cancer	1.87e-05	0.000242	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—CYP3A4—bone cancer	1.76e-05	0.000228	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—GSTP1—bone cancer	1.6e-05	0.000207	CbGpPWpGaD
Itraconazole—CYP3A7—Metabolism—PTGS2—bone cancer	1.52e-05	0.000196	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—GSTP1—bone cancer	1.51e-05	0.000195	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—ENO2—bone cancer	1.47e-05	0.00019	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—DHFR—bone cancer	1.36e-05	0.000176	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—GNA11—bone cancer	1.27e-05	0.000164	CbGpPWpGaD
Itraconazole—CYP2B6—Metabolism—PTGS2—bone cancer	1.12e-05	0.000145	CbGpPWpGaD
Itraconazole—CYP2E1—Metabolism—PTGS2—bone cancer	1.1e-05	0.000142	CbGpPWpGaD
Itraconazole—CYP3A5—Metabolism—PTGS2—bone cancer	1.1e-05	0.000142	CbGpPWpGaD
Itraconazole—CYP1A1—Metabolism—PTGS2—bone cancer	1.04e-05	0.000134	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—GSTP1—bone cancer	9.86e-06	0.000127	CbGpPWpGaD
Itraconazole—ABCB1—Metabolism—PTGS2—bone cancer	8.29e-06	0.000107	CbGpPWpGaD
Itraconazole—CYP2D6—Metabolism—PTGS2—bone cancer	7.81e-06	0.000101	CbGpPWpGaD
Itraconazole—CYP3A4—Metabolism—PTGS2—bone cancer	5.11e-06	6.6e-05	CbGpPWpGaD
